Skip to the page

Data / Form D filings / SONIRE Therapeutics Inc.

SONIRE Therapeutics Inc.: Form D filing

SONIRE Therapeutics Inc., a health care company in Palo Alto, CA, filed a Form D with the SEC in 2026. The latest, on April 15, 2026, reports $13.5 million sold of a $13.5 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
214 HOMER AVE, Palo Alto, CA, 94301
Phone
(650) 460-9879
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2129660

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 15, 2026New notice$13,499,802$13,499,8021Mar 31, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Tohru SatohExecutive Officer, Director, Promoter
Koji YasudaDirector
Jun OkamotoDirector
Auriel AugustDirector
Dennis McWilliamsDirector

Other health care companies in California that filed recently

Every Form D from the week of Apr 13, 2026 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what SONIRE Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.